adcelannotate = {"mobilepaywallcategory" : "MOBILE_PREM-LOCAL","nativepaywallcategory" : "NATIVE_PREM-LOCAL"};Mike Carter tried to rid his body of hepatitis C twice before, using miserable and less-effective treatments that came before a new class of drugs that is reshaping how the potentially fatal liver disease is found and treated. Carter, 63, of Delaware, is one of the new success stories.